Wednesday January 22, 2020 04:14

PHARMACEUTICAL Press Releases

บริษัทยาจีน GPHL ตั้งสำนักงานใหญ่ระหว่างประเทศที่มาเก๊า มุ่งสนับสนุนการพัฒนาเศรษฐกิจของมาเก๊า ทั่วไป—07 Jan 20

ปี 2563 ถือเป็นปีแห่งการเริ่มต้นโครงการสำคัญหลายโครงการที่มีวัตถุประสงค์เพื่อส่งเสริมความร่วมมือระหว่างมณฑลกวางตุ้งและเขตบริหารพิเศษมาเก๊า โดยเมื่อวันที่ 3 มกราคมที่ผ่านมาได้มีการก่อตั้งบริษัท Guangzhou Pharmaceutical Group (Macau) International

GPHL#s international headquarters settle in Macao, first project during the fifth-term government of Macao SAR General—06 Jan 20

GUANGZHOU, China--6 Jan--Xinhua-AsiaNet/InfoQuest

The beginning of 2020 witnessed key projects promoting the cooperation between Guangdong and Macao. On January 3, Guangzhou Pharmaceutical Group (Macau) International Development Co., Ltd. (hereunder referred to as "the company") was established in Macao. Ho Lat Seng, Chief Executive of the Macao Special Administrative Region, wrote a congratulatory letter for its contribution to the industrial diversification and new momentum, and thus a moderately diversified economic development in Macao.

The company is established by Guangzhou Pharmaceutical Holdings Limited (GPHL) in cooperation with Guangdong Namyue Group, Guangdong's leading enterprise in Macao and True Point Global Limited, a Macao enterprise. Positioned as a platform for GPHL's international business, it is committed to being a new growth pole with international competitiveness to take a lead in the Guangdong-Hong Kong-Macao Greater Bay Area while covering the Southeast Asia and Portuguese-speaking countries. It aims to deepen the pharmaceutical cooperation in the Area and promote the moderately diversified economic development of Macao and accelerate the internationalization layout of GPHL.

Li Chuyuan, Chairman of GPHL, said that the shareholding rights structure of the company, while contributing to the integrated deve

CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Heathcare—02 Jan 20

CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E investment led by New Alliance Capital. The investment included participation

TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE#s generic General—23 Dec 19

The operation will accelerate TOWA's overseas business presence and provide high-quality and value-added generic medicines to patients. TOWA PHARMACEUTICAL CO.,LTD. (Osaka, Japan) (TOWA) and ESTEVE (Barcelona, Spain) announced today that TOWA will

Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Heathcare—20 Nov 19

Excelra, a leading global Data and Analytics Company today announced a Drug Repurposing collaboration with Osaka-based Maruho – a pharmaceutical company specialising in Dermatology. Under the agreement, the Drug Repurposing Data Scientists and

#IP determined to take INTERPHARMA brand to the top of healthcare and well-being with innovative Events—05 Nov 19

Inter Pharma Public Company Limited ("IP"), developer and distributor of Wellness and Anti-Aging Products and Aesthetic innovation Products for human and Companion Animal Health Products and Livestock Products, formally becomes a publicly-listed company

Green Valley ประกาศข่าวดี ยา Oligomannate ได้รับการอนุมัติจากทางการจีนสำหรับใช้รักษาโรคอัลไซเมอร์เล็ ทั่วไป—04 Nov 19

Shanghai Green Valley Pharmaceuticals (Green Valley) ประกาศในวันนี้ว่า สำนักงานผลิตภัณฑ์ทางการแพทย์แห่งชาติจีน (NMPA) ได้อนุมัติยา Oligomannate (GV-971) ในฐานะยาใหม่สำหรับรักษาโรคอัลไซเมอร์เล็กน้อยถึงปานกลาง

Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer#s General—04 Nov 19

Shanghai Green Valley Pharmaceuticals (Green Valley) today announced that China's National Medical Products Administration (NMPA) has approved Oligomannate (GV-971) as new drug for the treatment of "mild to moderate Alzheimer's disease (AD) and improving

BGIC Join Hands With Genexine Inc. Of South Korea To Support Future Development of Thai Events—26 Sep 19

"BGIC", Thailand's leading biotechnology developer, joins hands with South Korea's giant bio-tech industry, Genexine Inc. and experts from all related sectors, in a development of Thailand's pharmaceutical industry, supported by dramatic growth of

Helsinn และ Mundipharma China Pharmaceutical ภูมิใจ ผลิตภัณฑ์ยา Akynzeo(R) สุขภาพ—25 Sep 19

Helsinn บริษัทเวชภัณฑ์สัญชาติสวิสที่มุ่งพัฒนาผลิตภัณฑ์คุณภาพสูงสำหรับการดูแลรักษาโรคมะเร็ง และ Mundipharma China Pharmaceutical ผู้นำตลาดด้านผลิตภัณฑ์จัดการกับความเจ็บปวด ร่วมกันประกาศในวันนี้ว่า สำนักงานผลิตภัณฑ์ทางการแพทย์แห่งชาติจีน (NMPA)

Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA#s approval of the oral Heathcare—25 Sep 19

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Mundipharma China Pharmaceutical, the market leader in pain management, today jointly announce that the National Medical Products Administration (NMPA) has

Kaspersky raises alarm over increasing targeted attacks against pharmaceuticals IT—25 Sep 19

Global cybersecurity company Kaspersky reveals an alarming trend observed in the pharmaceutical industry – a year-on-year steady increase on the number of devices being attacked by cybercriminals. From 44% of machines infected in 2017 and a 1%

Advanced Aesthetic Technologies ประกาศจับมือ China National Biotec Group General—20 Sep 19

Advanced Aesthetic Technologies, Inc. (AAT) ผู้นำด้านเทคโนโลยีเสริมความงามด้วยซิลิโคนเจล และ China National Biotec Group (CNBG) บริษัทในเครือ China National Pharmaceutical Group Corporation (SINOPHARM)

Advanced Aesthetic Technologies and China National Biotec Group Announce Strategic General—20 Sep 19

Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, and China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM) today announced the execution of strategic

Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of Heathcare—12 Sep 19

Strekin AG (www.strekin.com), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, placebo-controlled, Phase 3

Strekin AG Secures Financing to Complete Development of STR001 in Sudden Sensorineural Hearing Loss Heathcare—03 Sep 19

Strekin AG (www.strekin.com), a clinical stage biopharmaceutical company, announced today that it has successfully closed a Series A financing round totaling CHF 2.82 Million from private investors. These funds will enable Strekin to conclude its ongoing

Photo Release: PReMA granted the Trade Association Prestige (TAP) Award General—22 Aug 19

The Pharmaceutical Research and Manufacturers Association (PReMA), represented by Mr. Viriya Chongphaisal, PPeMA's president, received the "Trade Association Prestige: First Dimension - Achievement from Mission" award as a result of the association's

PReMA granted the Trade Association Prestige (TAP) Award 2019 Events—22 Aug 19

The Pharmaceutical Research and Manufacturers Association (PReMA), represented by Mr. Viriya Chongphaisal, PPeMA's president, received the "Trade Association Prestige: First Dimension - Achievement from Mission" award as a result of the association's

Xinhua Silk Road: Tasly remains China#s 2019 National Tech Innovation Demonstration Heathcare—16 Aug 19

Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country's review of National Technology Innovation Demonstration Enterprise in 2019, thanks to its continuous innovations made in the recent

@BactLAB(TM) แอปนับจำนวนโคโลนีของแบคทีเรีย พร้อมให้บริการทั่วโลกแล้วตั้งแต่บัดนี้ สุขภาพ—06 Aug 19

บริษัท นิสซุย ฟาร์มาซูติคอล จำกัด (Nissui Pharmaceutical Co., Ltd.) ในโตเกียว มีความยินดีที่จะประกาศว่า แอปพลิเคชัน @BactLAB(TM) ที่ใช้ Amazon Web Service (AWS) Cloud และเทคโนโลยีปัญญาประดิษฐ์ (AI) ในการนับจำนวนโคโลนีของแบคทีเรียอย่างรวดเร็วและง่ายดาย

@BactLAB(TM), Bacterial Colony-counting Service, Now Available Globally Heathcare—05 Aug 19

Nissui Pharmaceutical Co., Ltd., based in Tokyo, is pleased to announce that @BactLAB(TM), an application that uses Amazon Web Service (AWS) Cloud and artificial intelligence (AI) technologies to enable quick and easy counting of bacterial colonies, is

Photo Release: EXIM Thailand Visits Thailands Leading Pharmaceutical Products Manufacturer and General—22 Jul 19

Mr. Pisit Serewiwattana (second right), President of Export-Import Bank of Thailand (EXIM Thailand), with EXIM Thailand's executives recently visited pharmaceutical products manufacturing and exporting factory in Nakhon Pathom. Welcomed by Mr. Chernporn

Young Living Acquires Nature#s Ultra General—19 Jul 19

Organic hemp farm infuses pure Certified Pharmaceutical Grade CBD containing Young Living essential oils and 0% THC. Young Living Essential Oils, the world leader in essential oils, announced today its acquisition of Nature's Ultra. Nature's Ultra, with

SI Group Announces Focused Sale Of Industrial Resin Business to ASK General—11 Jul 19

Agreement Includes Products, Technology and Manufacturing Assets in Brazil, India & South Africa SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, announced

Daewoong Pharmaceutical participated in the IMCAS Asia 2019 to introduce the excellence of Heathcare—09 Jul 19

Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in IMCAS Asia 2019 held in Bali, Indonesia July 5-7, 2019 to introduce the excellence of NABOTA(R) (Prabotulinumtoxin A). The 13th year

Photo Release: The Doctor Kasem Pangsrivongse Foundation Funds Over 1.7 Million Baht for Pharmacy General—01 Jul 19

Tirapongse Pangsrivongse (4th left), Chairman of Doctor Kasem Pangsrivongse Foundation, donated for the 3rd consecutive year over 1,797,265 Baht to 23 funds to support pharmacy students and Thai pharmacists in scholarships and pharmaceutical research.

โดโมฮอร์น ริงเคิล จัดงานครบรอบ 1 ปีในไทย พร้อมเปิดตัว จ๋า-ยศสินี Brand Endorser ทั่วไป—18 Jun 19

บริษัท ไซชุนกัน ฟาร์มาซูติคอล (ประเทศไทย) จำกัด (Saishunkan Pharmaceutical (Thailand) Co.,Ltd.) จัดงานครบรอบ 1 ปีในประเทศไทยของผลิตภัณฑ์บำรุงผิว "โดโมฮอร์น ริงเคิล" (Domohorn Wrinkle) โดยมี มร. โนบุฟุมิ ยามาดะ ผู้บริหารจัดการแผนกต่างประเทศ บริษัท

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Heathcare—21 May 19

Ori Yehudai: "I took a company worth $3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will be to build an industrial pharmaceutical company with the strictest standards, we had two such plants, and

Hangzhou attracts RMB1.5 billion investments in bio-pharmaceutical projects in Heathcare—16 May 19

Hangzhou, capital of east China's Zhejiang Province, has seen seven bio-pharmaceutical projects implemented in the first quarter of the year, with a total investment of 1.5 billion yuan, according to the latest data of the Hangzhou Investment Promotion

SI Group Announces New President And Chief Executive Officer General—12 Mar 19

SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, announced today the appointment of David Bradley as the company's new President & Chief Executive Officer,